JP2012519657A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012519657A5 JP2012519657A5 JP2011550669A JP2011550669A JP2012519657A5 JP 2012519657 A5 JP2012519657 A5 JP 2012519657A5 JP 2011550669 A JP2011550669 A JP 2011550669A JP 2011550669 A JP2011550669 A JP 2011550669A JP 2012519657 A5 JP2012519657 A5 JP 2012519657A5
- Authority
- JP
- Japan
- Prior art keywords
- charged
- composition
- stabilizer
- group
- cyclic polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20854109P | 2009-02-25 | 2009-02-25 | |
| US61/208,541 | 2009-02-25 | ||
| US26994409P | 2009-07-01 | 2009-07-01 | |
| US61/269,944 | 2009-07-01 | ||
| US27136409P | 2009-07-20 | 2009-07-20 | |
| US61/271,364 | 2009-07-20 | ||
| US27929309P | 2009-10-19 | 2009-10-19 | |
| US61/279,293 | 2009-10-19 | ||
| US12/711,979 | 2010-02-24 | ||
| PCT/IB2010/000502 WO2010097700A1 (en) | 2009-02-25 | 2010-02-24 | Bendamustine cyclopolysaccharide compositions |
| US12/711,979 US8436032B2 (en) | 2009-02-25 | 2010-02-24 | Bendamustine cyclopolysaccharide compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012519657A JP2012519657A (ja) | 2012-08-30 |
| JP2012519657A5 true JP2012519657A5 (enExample) | 2012-11-22 |
| JP5654498B2 JP5654498B2 (ja) | 2015-01-14 |
Family
ID=42631521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011550669A Active JP5654498B2 (ja) | 2009-02-25 | 2010-02-24 | ベンダムスチン環状多糖組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8436032B2 (enExample) |
| EP (2) | EP2400987B1 (enExample) |
| JP (1) | JP5654498B2 (enExample) |
| KR (1) | KR101798951B1 (enExample) |
| CN (2) | CN102935080A (enExample) |
| AU (1) | AU2010217297A1 (enExample) |
| CA (1) | CA2753641C (enExample) |
| ES (2) | ES2675620T3 (enExample) |
| HU (1) | HUE038234T2 (enExample) |
| NO (1) | NO2792369T3 (enExample) |
| RU (2) | RU2591804C2 (enExample) |
| WO (1) | WO2010097700A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102935080A (zh) | 2009-02-25 | 2013-02-20 | 休普拉特克药品有限公司 | 苯达莫司汀环多糖组合物 |
| EP3158991B1 (en) | 2010-01-28 | 2021-03-17 | Eagle Pharmaceuticals, Inc. | Formulations of bendamustine |
| WO2011103150A2 (en) * | 2010-02-18 | 2011-08-25 | Cephalon, Inc. | Lyophilized preparations of bendamustine |
| US20110207764A1 (en) * | 2010-02-23 | 2011-08-25 | Valery Alakhov | Cyclopolysaccharide compositions |
| US8383663B2 (en) | 2010-07-19 | 2013-02-26 | Supratek Pharma Inc. | Bendamustine anionic-catioinic cyclopolysaccharide compositions |
| RS57063B1 (sr) * | 2011-09-18 | 2018-06-29 | Euro Celtique Sa | Farmaceutska kompozicija koja sadrži inhibitor hdac i ciklopolisaharid |
| TWI573792B (zh) | 2012-02-01 | 2017-03-11 | 歐陸斯迪公司 | 新穎治療劑 |
| HRP20230276T1 (hr) | 2012-03-20 | 2023-04-28 | Eagle Pharmaceuticals, Inc. | Tekući pripravci bendamustina za uporabu u postupku liječenja stanja koja reagiraju na bendamustin kod pacijenata kojima za primjenu trebaju reducirani volumeni |
| EP4360621A3 (en) | 2012-03-20 | 2024-05-22 | Eagle Pharmaceuticals, Inc. | Formulations of bendamustine |
| US20230241218A1 (en) * | 2012-07-10 | 2023-08-03 | Eagle Pharmaceuticals, Inc. | Formulations of bendamustine |
| EP2925327B1 (en) * | 2012-11-30 | 2024-01-10 | The Regents of The University of California | Allopregnanolone for treating, reducing or mitigating symptoms of post-partum depression |
| CN105491886B (zh) * | 2013-08-27 | 2019-01-29 | V·沃道里斯 | 苯达莫司汀医药组合物 |
| GB201409488D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409485D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409471D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| WO2018068832A1 (en) | 2016-10-11 | 2018-04-19 | Euro-Celtique S.A. | Hodgkin lymphoma therapy |
| GB201709405D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating ovarian cancer |
| GB201709403D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating sarcoma |
| GB201709406D0 (en) | 2017-06-13 | 2017-07-26 | Euro-Cletique S A | Compounds for treating TNBC |
| GB201709402D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating t-pll |
| RU2020115024A (ru) * | 2017-10-05 | 2021-11-08 | Тьюб Фармасьютикалз Гмбх | Препараты бендамустина для перорального введения |
| US11730815B2 (en) * | 2018-11-26 | 2023-08-22 | Good Health, Llc | Stable liquid pharmaceutical compositions comprising bendamustine |
| JP2022522928A (ja) | 2018-12-18 | 2022-04-21 | ムンディファーマ・インターナショナル・コーポレーション・リミテッド | 多発性骨髄腫を治療するための化合物 |
| CN111557904A (zh) * | 2020-04-09 | 2020-08-21 | 比卡生物科技（广州）有限公司 | 苯达莫司汀组合物及其用途 |
| US20220304983A1 (en) * | 2020-04-09 | 2022-09-29 | Bika Biotech (Guangzhou) Co., Ltd | Bendamustine composition and use thereof |
| US20240148696A1 (en) | 2022-10-25 | 2024-05-09 | Softkemo Pharma Inc. | Lyophilized bendamustine-cyclodextrin composition |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD159289A1 (de) * | 1981-06-01 | 1983-03-02 | Uwe Olthoff | Verfahren zur herstellung stabiler injektionsloesungen von n-lostverbindungen |
| US6407079B1 (en) | 1985-07-03 | 2002-06-18 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation |
| US5068226A (en) * | 1987-12-07 | 1991-11-26 | Cyclex, Inc. | Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies |
| US5602112A (en) | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
| DE59607089D1 (de) * | 1995-03-10 | 2001-07-19 | Roche Diagnostics Gmbh | Polypeptid-enthaltende pharmazeutische darreichungsformen in form von mikropartikeln und verfahren zu deren herstellung |
| ES2159726T3 (es) * | 1995-03-10 | 2001-10-16 | Roche Diagnostics Gmbh | Formas de administracion farmaceuticas que contienen polipeptidos, en forma de microparticulas, y procedimiento para su fabricacion. |
| US6624141B1 (en) | 1999-03-17 | 2003-09-23 | The Regents Of The University Of Michigan | Protamine fragment compositions and methods of use |
| DE10204792A1 (de) * | 2002-02-06 | 2003-08-14 | Merck Patent Gmbh | Lyophilisierte Zubereitung enthaltend Immuncytokine |
| MXPA04010325A (es) | 2002-04-19 | 2005-06-08 | Novartis Ag | Biomateriales novedosos, su preparacion y uso. |
| RU2357750C2 (ru) * | 2002-12-31 | 2009-06-10 | Элтус Фармасьютикалз Инк. | Кристаллы человеческого гормона роста и способы их получения |
| AU2004312095A1 (en) * | 2003-12-31 | 2005-07-21 | Cydex Pharmaceuticals, Inc. | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| WO2005094830A1 (en) * | 2004-03-30 | 2005-10-13 | Pfizer Products Inc. | Combinations of signal transduction inhibitors |
| KR20070030264A (ko) * | 2004-06-07 | 2007-03-15 | 나스텍 파마수티컬 컴퍼니 인코포레이티드 | 단백질 또는 폴리펩티드 안정제 성분을 함유하지 않은인터페론 베타의 비강내 투여를 위한 제형들 |
| AU2005268929A1 (en) * | 2004-08-03 | 2006-02-09 | Royal College Of Surgeons In Ireland | Phenytoin formulations, and uses thereof in wound healing |
| JP2008519032A (ja) * | 2004-11-03 | 2008-06-05 | キュラジェン コーポレイション | Ｆｇｆ−２０の調合物、生成方法および使用 |
| WO2006065392A2 (en) * | 2004-11-05 | 2006-06-22 | Cephalon, Inc. | Cancer treatments |
| US20060128653A1 (en) * | 2004-12-10 | 2006-06-15 | Chunlin Tang | Pharmaceutical formulation of decitabine |
| CN101119708B (zh) * | 2005-01-14 | 2014-12-24 | 赛福伦公司 | 苯达莫司汀冻干药物组合物 |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| PL1848813T3 (pl) | 2005-01-28 | 2013-09-30 | Univ Brigham Young | Aktywacja glikolipidem bakteryjnym komórek NKT podlegających restrykcji CD1d |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| CN1846685A (zh) | 2006-01-25 | 2006-10-18 | 济南帅华医药科技有限公司 | 含苯达莫司汀和其增效剂的缓释注射剂 |
| WO2008063910A2 (en) | 2006-11-08 | 2008-05-29 | Novavax, Inc. | Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions |
| US8425459B2 (en) * | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
| CN101657203B (zh) | 2007-03-02 | 2012-09-05 | 卧龙岗大学 | 抗癌药的组合物及递送方法 |
| CN101219113A (zh) | 2008-01-28 | 2008-07-16 | 济南帅华医药科技有限公司 | 含苯达莫司汀的复方抗癌缓释注射剂 |
| CN102935080A (zh) | 2009-02-25 | 2013-02-20 | 休普拉特克药品有限公司 | 苯达莫司汀环多糖组合物 |
| CN101606934B (zh) | 2009-07-27 | 2011-09-28 | 江苏奥赛康药业有限公司 | 盐酸苯达莫司汀组合物 |
-
2010
- 2010-02-24 CN CN2012104076231A patent/CN102935080A/zh active Pending
- 2010-02-24 US US12/711,979 patent/US8436032B2/en active Active
- 2010-02-24 RU RU2011138844/15A patent/RU2591804C2/ru not_active Application Discontinuation
- 2010-02-24 ES ES14177306.9T patent/ES2675620T3/es active Active
- 2010-02-24 HU HUE14177306A patent/HUE038234T2/hu unknown
- 2010-02-24 CA CA2753641A patent/CA2753641C/en active Active
- 2010-02-24 AU AU2010217297A patent/AU2010217297A1/en not_active Abandoned
- 2010-02-24 JP JP2011550669A patent/JP5654498B2/ja active Active
- 2010-02-24 ES ES10745872.1T patent/ES2525257T3/es active Active
- 2010-02-24 NO NO14177306A patent/NO2792369T3/no unknown
- 2010-02-24 CN CN2010800183017A patent/CN102421451B/zh active Active
- 2010-02-24 KR KR1020117022330A patent/KR101798951B1/ko active Active
- 2010-02-24 EP EP10745872.1A patent/EP2400987B1/en active Active
- 2010-02-24 RU RU2016124871A patent/RU2734236C2/ru not_active Application Discontinuation
- 2010-02-24 WO PCT/IB2010/000502 patent/WO2010097700A1/en not_active Ceased
- 2010-02-24 EP EP14177306.9A patent/EP2792369B1/en active Active
-
2013
- 2013-03-11 US US13/793,442 patent/US8703964B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012519657A5 (enExample) | ||
| RU2011138844A (ru) | Композиции бендамустина и циклополисахарида | |
| JP2015536356A5 (enExample) | ||
| EP3321367A3 (en) | Vector | |
| BR112015023168A2 (pt) | composições de dicetopiperazina microcristalina e métodos | |
| JP2019530462A5 (enExample) | ||
| JP2016538885A5 (enExample) | ||
| JP2015513897A5 (enExample) | ||
| Barros et al. | A review of solute encapsulating nanoparticles used as delivery systems with emphasis on branched amphipathic peptide capsules | |
| JP2011088908A5 (enExample) | ||
| BR112015002055A2 (pt) | acetato succinato de hidroxialquil metil celulose, composição, dispersão sólida, processo para produzir uma dispersão sólida, forma de dosagem e cápsula de envoltório | |
| WO2015023461A3 (en) | Influenza nucleic acid molecules and vaccines made therefrom | |
| WO2015048498A3 (en) | Carrier-free biologically-active protein nanostructures | |
| JP2014517694A5 (enExample) | ||
| WO2014145932A3 (en) | Specific multivalent virus-like particle vaccines and uses thereof | |
| WO2015156870A3 (en) | Biopolymer-mediated assembly of nanoparticles using genetically encoded proteins | |
| JP2015533791A5 (enExample) | ||
| JP2015506705A5 (enExample) | ||
| JP2019531092A5 (enExample) | ||
| EP2672992A4 (en) | FOR A HEPATITIS B-VIRUS CORE PROTEIN, CODING NUCLEIC ACID MOLECULE AND VACCINE WITH IT | |
| JP2009256608A5 (enExample) | ||
| JP2011195814A5 (enExample) | ||
| JP2014529399A5 (enExample) | ||
| WO2012082803A3 (en) | Method for inducing an immune response against avian, swine, spanish, h1n1, h5n9 influenza viruses and formulations thereof | |
| HK1216544A1 (zh) | 病毒載體納米膠囊靶向基因治療及其製備 |